Swanbridge Capital
Overview
Swanbridge Capital is a venture capital firm based in Rotterdam, Netherlands that seeks to invest in the life science, therapeutics, diagnostics, medical devices, and healthcare sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DegenRx B.V. | Dec 2018 | Series A | Co-investor |
| Flindr Therapeutics | Apr 2024 | Series A | Co-investor |
| Pan Cancer T | Jul 2024 | Seed | Co-investor |
Key People
Hans Schikan
Chair of the Investor Board
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Swanbridge Capital based?
Swanbridge Capital is headquartered in Rotterdam, Netherlands.
When was Swanbridge Capital founded?
Swanbridge Capital was founded in 2016.
How many portfolio companies does Swanbridge Capital have?
Swanbridge Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Swanbridge Capital's portfolio?
Portfolio companies visible on Caplight include DegenRx B.V., Flindr Therapeutics, Pan Cancer T.
What was Swanbridge Capital's most recent investment shown here?
Swanbridge Capital's most recent investment in this portfolio sample was in Pan Cancer T in 2024.
What sectors does Swanbridge Capital focus on?
Swanbridge Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Swanbridge Capital focus on?
Swanbridge Capital typically invests at the Early stage.